Genetic analysis of haemophilia A in Taiwan

Haemophilia

Volumn 16, Issue 3, 2010, Pages 538-544

  Chen, Y C ^a,b   Hu, S H ^a   Cheng, S N ^a,c   Chao, T Y ^a,b  

^a Hemophilia Care and Research Center   (Taiwan)

^b Department of Internal Medicine Division of Hematology   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

DHPLC; Factor VIII gene; Haemophilia A; Intron 1 inversion; Intron 22 inversion; Reverse transcript PCR

Indexed keywords

BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 8 INHIBITOR;

ARTICLE; CAUCASIAN; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; HEMOPHILIA A; HUMAN; INDEL MUTATION; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN;

ADULT; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOSOME INVERSION; DNA MUTATIONAL ANALYSIS; EXONS; FACTOR VIII; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HEMOPHILIA A; HUMANS; INTRONS; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK; TAIWAN;

EID: 77953603802     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2009.02180.x     Document Type: Article

References (37)

1. Tuddenham E, Cooper D. Book reviews: the molecular genetics of haemostasis and its inherited disorders. Br J Haematol 1995, 90:234.
2. Gitschier J, Wood WI, Goralka TM. Characterization of the human factor VIII gene. Nature 1984, 312:326-30.
3. The Haemophilia A Mutation, Structure, Test and Resource Site (HAMSTeRS) http://europium.csc.mrc.ac.uk/WebPages/Main/main.htm, Available at: (last accessed on 21 September 2009)
4. Simone JV, Vanderheiden J, Abildgaard CF. A semi-automatic one-stage factor 8 assay with a commercially prepared standard. J Lab Clin Med 1967, 69:706-12.
5. Liu Q, Sommer SS. Subcycling-PCR for multiplex long-distance amplification of regions with high and low GC content application to the inversion hotspot in the factor VII gene. Bio Techniques 1998, 25:1022-8.
6. Liu Q, Nozari G, Sommer SS. Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot mutation in hemophilia A. Blood 1998, 92:1458-9.
7. Bagnall RD, Waseem, Green PM. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 2002, 99:168-74.
8. Becker J, Schwaab R, Möller-Taube A. Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type dependent sex ratio of mutation frequencies. Am J Hum Genet 1996, 58:657-70.
9. Schwaab R, Oldenburg J, Schwaab U. Characterization of mutations within the factor VIII gene of 73 unrelated mild and moderate haemophiliacs. Br J Haematol 1995, 91:458-64.
10. Oldenburg J, Ivaskevicius V, Rose S. Evaluation of DHPLC in the analysis of hemophilia A. J Biochem Biophys Methods 2001, 47:39-51.
11. Ahmed RPH, Ivaskevicius V, Kannan M. Identification of 32 novel mutations in the factor VIII gene in Indian patients with hemophilia A. Haematologica 2005, 90:283-4.
12. Oefner PJ, Underhill PA. Comparative DNA sequence by denaturing high performance liquid chromatography (DHPLC). Am J Hum Genet 1995, 57:A266.
13. Oefner PJ, Underhill PA. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). Curr Protoc Hum Genet 1998, 19:7101-12.
14. Figuereido MS, Brownlee GG. Cis-acting elements and transcription factors involved in the promoter activity of the human factor VIII gene. J Biol Chem 1995, 270:11828-36.
15. Bogdanova N, Markoff A, Eisert R. Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A. Hum Mutat 2007, 28:54-60.
16. El-Maarri O, Herbiniaux U, Graw J. Analysis of mRNA in hemophilia A patients with undetectable mutations reveals normal splicing in the factor VIII gene. J Thromb Haemost 2005, 3:332-9.
17. Vinciguerra C. Genotyping study of French hemophilia A patients treated with Refacto. Hemophilia 2004, 10(Suppl. 3):78.
18. Hill M, Deam S, Gordon B. Mutation analysis in 51 patients with haemophilia A: report of 10 novel mutations and correlations between genotype and clinical phenotype. Haemophilia 2005, 11:133-41.
19. Jayandharan G, Shaji RV, Baidya S. Identification of factor VIII gene mutations in 101 patients with haemophilia A: mutation analysis by inversion screening and multiplex PCR and CSGE and molecular modelling of 10 novel missense substitutions. Haemophilia 2005, 11:481-91.
20. Han JY, Lee JN, Lee SY. Identification of factor VIII gene mutations and carrier detection in Korean haemophilia A patients. Haemophilia 2007, 13:331-3.
21. Repesse Y, Slaoui M, Ferrandiz D. Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development. J Thromb Haemost 2007, 5:1469-76.
22. Djambas Khayat C, Salem N, Chouery E. Molecular analysis of F8 in Lebanese haemophilia A patients novel mutations and phenotype genotype correlation. Haemophilia 2008, 14:709-16.
23. Lin SR, Chang SC, Lee CC. Genetic diagnosis of hemophilia A of Chinese origin. British J Haemotol 1995, 91:722-7.
24. Gau JP, Hsu HC, Ho CH. Rapid detection of intron 22 inversions of the factor VIII gene in Chinese patients with severe hemophilia A. J Chin Med Assoc 2003, 66:518-22.
25. Li T, Dai J, Wu JS. Intron 1 and 22 inversions in factor VIII gene in patients with haemophilia A (text in Chinese). Zhonghonghua Xue Ye Xue Za Zhi 2009, 30:150-3.
26. Kazuyoshi F, Hiroyuki N, Shogo M. Inversions of the factor VIII gene in Japanese patients with severe hemophilia A. Int J Hematol 2004, 79:303-6.
27. Naylor JA, Green PM, Rizza CR. Factor VIII gene explains all cases of hemophilia A. Lancet 1992, 340:1066-7.
28. Lakich D, Kazazian H, Antonarakis SE. Inversions disrupting the factor VIII gene are a common cause of severe hemophilia A. Nat Genet 1993, 5:236-41.
29. Jenkins PV, Goldman CE, MccCraw A. Analysis of intron 22 inversion of the factor VIII gene in severe hemophilia A: implication for the genetic counseling. Blood 1994, 84:2197-201.
30. Antonarakis SE, Rossiter JP, Young M. Factor VIII gene inversions in severe hemophilia A: result of an international consortium study. Blood 1995, 86:2206-12.
31. Rossetti LC, Candela M, Bianco RP. Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature. Blood Coagul Fibrinolysis 2004, 15:569-72.
32. Oldenburg J, El-Maarri O, Schwaab R. Inhibitor development in correlation to factor VIII genotype. Haemophilia 2002, 8(Suppl. 2):23-9.
33. Morado M, Villar V, Yuste J. Prophylactic treatment effects on inhibitor risk: experience in one center. Haemophilia 2005, 11:79-83.
34. Pittman DD, Alderman EM, Tomkinson KN. Biochemical, immunological, and in vivo function characterization of B-domain-deleted factor VIII. Blood 1993, 81:2925-35.
35. Kevin RV, Deepa KM, Diane MW. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood 2007, 109:3713-24.
36. Favier R, Lavergne JM, Costa JM. Unbalanced X-chromosome inactivation with a novel FVIII gene mutation resulting in severe hemophilia A in a female. Blood 2000, 96:4373-5.
37. Goodeve A. Molecular genetic testing of hemophilia A. Semin Thromb Hemost 2008, 34:491-501.